Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Search
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)
Hang Seng
17,626.29
(-0.05%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,676.34
(0.2%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,399.10
(0.18%)
Lithium
41.42
(1.37%)
Iron Ore
101.15
(-2.25%)

Algorae Pharmaceuticals (ASX:$1AI) collaborates on pre-clinical studies for AI-168 drug candidate

Algorae Pharmaceuticals collaborates with Monash University for pre-clinical studies on AI-168 drug candidate


Algorae Pharmaceuticals Limited (ASX:$1AI) has partnered with Monash University to conduct pre-clinical studies on its AI-168 drug candidate for cardiovascular diseases. The studies aim to assess the drug's efficacy in various cardiovascular models and compare it to existing treatments. Results are expected over a 12-month period and will guide the next steps in the R&D program for AI-168.

Insights from Dr Kristen Bubb on the pre-clinical studies


Dr Kristen Bubb, a senior research fellow at the Victorian Heart Institute, Monash University, is leading the pre-clinical studies on AI-168. The studies will focus on understanding the drug's mechanism of action across different cardiovascular diseases. The results will play a crucial role in shaping the future of AI-168's development and potential patent applications.

Summary of Algorae Pharmaceuticals' collaboration and patent application


Algorae Pharmaceuticals has initiated pre-clinical studies with Monash University to evaluate its AI-168 drug candidate for cardiovascular diseases. The collaboration aims to assess the drug's efficacy and guide further R&D efforts. Additionally, the company has filed a provisional patent application for AI-168, marking the commencement of a new research and development project. The potential market for new drugs targeting cardiovascular diseases is substantial, driven by the increasing global demand for effective treatments. Algorae's focus on developing intellectual property assets aligns with its broader strategy, positioning the company for future growth and innovation in the pharmaceutical industry.

Sourcehttps://announcements.asx.com.au/asxpdf/20231123/pdf/05xphgnqss4hnn.pdf

Share to Social
0 Comments
Inline Feedbacks
View all comments

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions